Predictors of attrition during one year of depression treatment: a roadmap to personalized intervention
- PMID: 19339845
- PMCID: PMC2866198
- DOI: 10.1097/01.pra.0000348364.88676.83
Predictors of attrition during one year of depression treatment: a roadmap to personalized intervention
Abstract
Objective: Attrition from treatment in the short and long term for major depressive disorder (MDD) is clearly an adverse outcome. To assist in tailoring the delivery of interventions to specific patients to reduce attrition, this study reports the incidence, timing, and predictors of attrition from outpatient treatment in public mental health clinics.
Methods: Outpatients with psychotic and nonpsychotic MDD receiving measurement-based care in the Texas Medication Algorithm Project (N=179) were evaluated to determine timing and rates of attrition as well as baseline sociodemographic, clinical, and attitudinal predictors of attrition.
Results: Overall, 23% (42/179) of the patients left treatment by 6 months, and 47% (84/179) left by 12 months. Specific beliefs about the impact of medication, such as its perceived harmfulness, predicted attrition at both 6 and 12 months. Younger age (P=0.0004) and fewer side effects at baseline (P=0.0376) were associated with attrition at 6 months. Younger age (P=0.0013), better perceived physical functioning (P=0.0007), and more negative attitudes about psychiatric medications at baseline (P=0.0075) were associated with attrition at 12 months.
Conclusions: Efforts to elicit attitudes about medications and tailoring educational and other retention interventions for patients with negative beliefs about antidepressants both when initiating a new medication and throughout treatment may reduce attrition. Particular focus on younger patients and those requiring frequent visits may be helpful.
Figures
Similar articles
-
What predicts attrition in second step medication treatments for depression?: a STAR*D Report.Int J Neuropsychopharmacol. 2009 May;12(4):459-73. doi: 10.1017/S1461145708009073. Epub 2008 Jul 9. Int J Neuropsychopharmacol. 2009. PMID: 18611293 Free PMC article. Clinical Trial.
-
Income and attrition in the treatment of depression: a STAR*D report.Depress Anxiety. 2009;26(7):622-33. doi: 10.1002/da.20541. Depress Anxiety. 2009. PMID: 19582825 Clinical Trial.
-
One-year clinical outcomes of depressed public sector outpatients: a benchmark for subsequent studies.Biol Psychiatry. 2004 Jul 1;56(1):46-53. doi: 10.1016/j.biopsych.2004.04.005. Biol Psychiatry. 2004. PMID: 15219472 Clinical Trial.
-
Novel Augmentation Strategies in Major Depression.Dan Med J. 2017 Apr;64(4):B5338. Dan Med J. 2017. PMID: 28385173 Review.
-
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.Lancet. 2018 Apr 7;391(10128):1357-1366. doi: 10.1016/S0140-6736(17)32802-7. Epub 2018 Feb 21. Lancet. 2018. PMID: 29477251 Free PMC article. Review.
Cited by
-
The association of baseline depressive symptoms and stress on withdrawal in a national longitudinal cohort: the REGARDS study.Ann Epidemiol. 2023 Aug;84:8-15. doi: 10.1016/j.annepidem.2023.05.007. Epub 2023 May 12. Ann Epidemiol. 2023. PMID: 37182817 Free PMC article.
-
Non-overweight depressed patients who respond to antidepressant treatment have a higher risk of later metabolic syndrome: findings from the METADAP cohort.Psychol Med. 2023 Jan 11;53(14):1-10. doi: 10.1017/S0033291722003919. Online ahead of print. Psychol Med. 2023. PMID: 36628576 Free PMC article.
-
Within Clinic Reliability and Usability of a Voice-Based Amazon Alexa Administration of the Patient Health Questionnaire 9 (PHQ 9).J Med Syst. 2022 May 10;46(6):38. doi: 10.1007/s10916-022-01816-0. J Med Syst. 2022. PMID: 35536347 Free PMC article. Clinical Trial.
-
The effects of self-management interventions on depressive symptoms in adults with chronic physical disease(s) experiencing depressive symptomatology: a systematic review and meta-analysis.BMC Psychiatry. 2021 Nov 20;21(1):584. doi: 10.1186/s12888-021-03504-8. BMC Psychiatry. 2021. PMID: 34800995 Free PMC article.
-
Patterns of care and dropout rates from outpatient mental healthcare in low-, middle- and high-income countries from the World Health Organization's World Mental Health Survey Initiative.Psychol Med. 2021 Sep;51(12):2104-2116. doi: 10.1017/S0033291720000884. Epub 2020 Apr 28. Psychol Med. 2021. PMID: 32343221 Free PMC article.
References
-
- Melfi CA, Chawla AJ, Croghan TW, et al. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry. 1998;55:1128–32. - PubMed
-
- Katon W, Von Korff M, Lin E, et al. Adequacy and duration of antidepressant treatment in primary care. Med Care. 1992;30:67–76. - PubMed
-
- Lin EHB, Von Korff M, Katon W, et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care. 1995;33:67–74. - PubMed
-
- Maddox JC, Levi M, Thompson C. The compliance with antidepressants in general practice. J Psychopharmacol. 1994;8:48–53. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
